Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,289,304 | 4,289,304 | 0 | $99.13M | $80.64M | 34.83% | -$18.49M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $108.15M | $58.49M | 25.26% | -$49.66M |
| Alumis Inc | 0 | 2,826,048 | +2,826,048 | $0 | $37.59M | 16.23% | +$37.59M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 1,035,396 | 1,035,396 | 0 | $34.77M | $31.24M | 13.49% | -$3.53M |
| Acelyrin Inc | 3,852,470 | 3,852,470 | 0 | $26.00M | $16.99M | 7.34% | -$9.01M |
| Elevation Oncology Inc | 2,696,133 | 2,434,255 | -261,878 | $13.83M | $6.57M | 2.84% | -$7.26M |